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Staphylococcus epidermidis have become important causes of nosocomial infections, as its pathogenesis is corre-
lated with the ability to form biofilms on polymeric surfaces. Production of poly-N-acetylglucosamine (PNAG) is
crucial for S. epidermidis biofilm formation and is synthesized by the gene products of the icaADBC gene cluster.
Production of PNAG/polysaccharide intercellular adhesin and biofilm formation are regulated by the alterna-
tive sigma factor, sB, and is influenced by a variety of environmental conditions including disinfectants and
other antimicrobial substances. The susceptibility of five S. epidermidis strains to antibiotics alone and in double
combination was previously tested. Our results demonstrated that some combinations are active and pres-
ent a general broad spectrum against S. epidermidis biofilms, namely rifampicin–clindamycin and rifampicin–
gentamicin. In the present study, it was investigated whether the combination of rifampicin with clindamycin
and gentamicin and these antibiotics alone influence the expression of specific genes (icaA and rsbU) of
S. epidermidis within biofilms using real-time polymerase chain reaction. The data showed that in most cases the
expression of both genes tested significantly increased after exposure to antimicrobial agents alone and in
combination. Besides having a similar antimicrobial effect, rifampicin combined with clindamycin and genta-
micin induced a lower expression of biofilm-related genes relatively to rifampicin alone. Associated with the
advantage of combinatorial therapy in avoiding the emergence of antibiotic resistance, this study demonstrated
that it can also cause a lower genetic expression of icaA and rsbU genes, which are responsible for PNAG/
polysaccharide intercellular adhesin production, and consequently reduce biofilm formation recidivism, rela-
tively to rifampicin alone.
Introduction
S taphylococcus epidermidis is a common commensalinhabitant of the healthy human skin and mucosa, but
also an increasing nosocomial pathogen in immuno-
compromised patients. Living at the edge between com-
mensalism and pathogenicity, S. epidermidis has developed
interesting strategies to conquer the hospital environment as
a novel ecological niche and to transform into a notorious
pathogen.32 S. epidermidis causes a great number of infec-
tions, as it is the most frequent causative agent of infections
of indwelling medical devices, such as peripheral or central
intravenous catheters.29 These infections usually commence
with the introduction of bacteria from the skin of the patient
or that of healthcare personnel.1,25 The increasing use of in-
vasive devices for diagnostics and therapeutic procedures
has contributed to an increase in the number of S. epidermidis
medical device-related infections, ranking this bacterium first
among the causative agents of nosocomial infections.
The tight pathogenic association is essentially linked to the
species’ ability to form adherent biofilms on artificial sur-
faces,30 which is the main virulence mechanism of S. epi-
dermidis. Biofilm-associated bacteria are 100–1,000 times less
susceptible to antibiotics than are planktonic cells.6 A num-
ber of factors have been postulated as mechanisms of
biofilm-associated antibiotic resistance, including binding of
antibiotics to the slime, poor penetration of antibiotic into the
biofilm, slow growth rate of organisms in the biofilm, high
bacterial density, and change in gene expression in biofilm
bacteria.6,33
Antibiotic combinations are being increasingly used as
therapeutic option as a result of the increasing appearance of
multiresistant microorganisms.21
Many S. epidermidis strains produce poly-N-acetylglucosamine
(PNAG), also named polysaccharide intercellular adhesin
(PIA) homopolymer, a crucial factor for biofilm forma-
tion, which surrounds and connects S. epidermidis cells in a
biofilm.20 Synthesis of PIA is essential for bacterial cell
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accumulation because it mediates cell-to-cell adhesion of
proliferating cells.12 In addition to its role as part of the ex-
tracellular biofilm matrix, PNAG/PIA has been found to
protect the bacterium from important mechanisms of innate
host defense, namely neutrophil killing, complement depo-
sition, immunoglobulins, and antimicrobial peptides.14,35
The correlation of the presence of PNAG/PIA with the in-
vasiveness of the bacterium may be due to the roles of this
exopolymer in biofilm formation and immune evasion.26
Two main putative determinants of S. epidermidis invasive-
ness have been identified: the ica genes, which regulate the
production of PNAG/PIA, and the insertion element IS256.
The latter is thought to contribute to the genetic adaptation
that may have a role during infection.36 The biosynthesis of
PNAG/PIA is accomplished by the gene products of the ica
(intercellular adhesion) locus,8,10,20 which comprises four
intercellular adhesion genes icaA, icaB, icaC, and icaD.23 The
expression of the ica operon and biofilm formation depends
on a variety of environmental conditions. The expression of
at least four unlinked genes (icaR,7 sB, the purR locus, and
sarA) is known to control PNAG/PIA synthesis at the level
of transcription.3,18,19 Production of PNAG/PIA is subject to
a range of regulatory influences,24 including many global
virulence regulators. PNAG/PIA and biofilm formation is
regulated by the alternative sigma factor sB, which is pre-
sumed to play a crucial role in the global regulation of gene
expression.11 RsbU is a positive regulator of the activity of
sB, the general stress-response factor of Gram-positive mi-
croorganisms.5 sB may act only indirectly via an additional,
unknown factor or rsbU may, by itself, be a regulator of
icaADBC transcription.12
Activation of PNAG/PIA expression by different stress
stimuli apparently uses different pathways. This implies that
a number of environmental conditions and regulatory sys-
tems can influence the expression of staphylococcal biofilms,
reflecting the magnitude of the complexity associated with
biofilm formation.27
In previous studies, we assessed the effect of various an-
tibiotics alone and in double combination against S. epi-
dermidis biofilms. Rifampicin combined with gentamicin and
clindamycin showed to be the most active combinations,
promoting reductions of about 3 log colony forming units
(CFUs) in biofilm cells in the majority of clinical isolates
tested. However, the effect of these treatments in the subse-
quent response of survival cells was never determined. Ac-
cordingly, the main goal of the present work was to assess
the expression of some genes of S. epidermidis, namely icaA
and rsbU, both responsible by PNAG/PIA production after
antibiotic treatment.
Materials and Methods
Bacterial strains and antimicrobial agents
In this study, five good-biofilm–producing and ica-
positive S. epidermidis strains were used: 117977, 132034,
150271, 1457, and 9142. The first three strains were kindly
provided by Dr. Howard Ceri, Department of Biological
Sciences, University of Calgary, Calgary, and the last two by
Dr. G. B. Pier, Channing Laboratory, Department of Medi-
cine, Brigham and Women’s Hospital, Harvard Medical
School, Boston. These strains are clinical isolates (isolated
from infected catheters) and were stored at 808C. Anti-
biotics tested were rifampicin, gentamicin, and clindamycin
(Sigma) and were used at break-point concentration. Inter-
pretation criteria for susceptibility testing were based on
National Committee for Clinical Laboratory Standards,22
now Clinical Laboratory Standards Institute (CLSI) guide-
lines (Table 1).
Biofilm formation
Several colonies of the isolates grown on tryptic soy agar
plates were suspended in saline (0.9% NaCl) to a density of
1.0 on the McFarland scale, as indicated by the manufacturer.
Then the bacterial suspension was resuspended in tryptic soy
broth to obtain a cellular concentration of circa 1107 CFU/
ml. This solution was used as inoculum for the MBEC
device (MBEC Biofilm Technologies Ltd.). The biofilms were
grown for 48 hours at 378C and 150 rpm on a rocking plat-
form where the shear force was created against the pegs
forming 96 equivalent biofilms. At the end of the incubation
period, a biofilm of approximately 6 logs per peg was
formed.
Biofilm challenge and recovery
The challenge plates were prepared using the antibiotics at
break-point concentration (Table 1) alone and in combination
(rifampicinþ clindamycin and rifampicinþ gentamicin). The
biofilms formed on the lid of the MBEC were rinsed twice
with 0.9% saline and placed into the challenge plate over-
night at 378C, 150 rpm on a rocking platform, and 95% rel-
ative humidity. Then, the challenged biofilms were rinsed
twice in saline and transferred to a recovery plate that con-
sisted of tryptic soy broth medium plus 1% Tween. Biofilms
were removed from all pegs at once by sonication for 8
minutes on high with an Aquasonic sonicator (model 250HT;
VWR Scientific).2 The vibration disrupted biofilms from the
surface of the 96 pegs into the recovery plate. Then, CFUs
were determined as follows: the recovery medium (contain-
ing the sonicated biofilms) was serially diluted. The biofilm
cultures (10-fold diluted) were spotted on tryptic soy agar
plates. Then the plates were incubated for 48 hours at 378C to
ensure maximum recovery of the surviving microorganisms
and CFUs were counted. The same protocol was repeated
and all samples were collected, preserved in RNAlater so-
lution (Ambion-Applied Biosystems), and kept at 808C for
further study of gene expression.
Genetic expression analysis
Primer design. Primers used for S. epidermidis icaA and
rsbU genes analysis by real-time polymerase chain reaction
(PCR) were designed using Primer3 web-based software
Table 1. Antibiotics’ Break Points
Break point (mg/ml)
Antibiotic Sensitive Intermediate Resistanta Reference22
Rifampicin 1 2 4 NCCLS
Gentamicin 4 8 16 NCCLS
Clindamycin 0.5 — 2 NCCLS
aConcentration used in bactericidal antibiotic test.
NCCLS, National Committee for Clinical Laboratory Standards.
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(http://fokker.wi.mit.edu\cgi-bin\primer3\primer3_www
.cgi)31 and are listed in Table 2. To verify the specificity of
each primer pair for its corresponding target gene, PCR
products were first amplified from 1457 strain genomic DNA
(data not shown).
RNA extraction. Total RNA of each sample was extracted
using the PureLink RNAMini Kit (Invitrogen) according to
the manufacturer’s recommended protocol. Potential DNA
contamination was removed during RNA purification pro-
cedure by On-column PureLink DNase treatment (Invitro-
gen). RNA concentration (ng/ml) and purity (OD260nm/
OD280nm) were assessed by spectrophotometric measure-
ments using a NanoDrop device (NanoDrop 1000 Spectro-
photometer, V3.6.0; Thermo Fisher Scientific, Inc.).
cDNA synthesis. To ensure equivalent starting amounts of
RNA from control and respective treated samples to be
converted into cDNA, appropriate dilutions in RNase-free
water were performed to obtain a final concentration of 2mg
of RNA. cDNA of each sample was synthesized using the
iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Inc.).
Each reaction contained 2.5 ml of iScript Reaction Mixþ
iScript Reverse Transcriptase and 7.5 ml of RNA template, in
accordance with the proportions recommended by the kit
manufacturer, making a final reaction volume of 10 ml.
Complete reaction mix was incubated in a thermocycler
(MyCycler; BioRad) with the following reaction protocol: 5
minutes at 258C, 30 minutes at 428C, and 5 minutes at 858C.
Quantitative real-time PCR. Real-time PCRs were per-
formed on a CFX96TM real-time PCR Detection System
(Bio-Rad Laboratories, Inc.). Each 20 ml of reaction mixture
contained 2ml of cDNA, 1ml of each primer (forward and
reverse primers), 10ml of 1 SsoFast EvaGreen Supermix
(Bio-Rad Laboratories, Inc.), and 6 ml of nuclease-free water.
Thermal cycling conditions were as follows: 3 minutes initial
denaturation at 958C, followed by 40 cycles of 5 seconds
denaturation at 958C, 10 seconds annealing/extension at
608C (this step was performed at 608C, concerning primers
efficiency previously determined [data not shown]). A melt
curve was inserted at the end of each run, with readings
from 658C to 958C, every 18C for 5 seconds, to confirm that
only the desired product was amplified.
Gene analysis and expression. Samples for real-time
PCRs were run in triplicate. Data were analyzed using the
CFX Manager version 1.6 (Bio-Rad Laboratories, Inc.) and
the relative quantification method (2DDCT; Livak and
Schmittgen),17 which describes the change in expression of
the target genes relative to the 16S rRNA reference genes
from untreated control samples,15,34 and the cycle threshold
values (CT; cycle at which each sample amplification curve
crosses a specific threshold) were averaged for triplicate
samples. The DCT values of the target genes were deter-
mined by normalizing to the endogenous control genes 16S
rRNA. These samples were subsequently subtracted from the
16S rRNA genes of the untreated control samples. The DDCT
was used to calculate relative expression using the following
formula: 2DDCT.9,16,17
The cDNA was validated by comparing with an RNA
sample not subjected to reverse transcriptase reaction, to
determine possible DNA contamination. All these no-reverse
transcriptase controls showed a DDCT above 10 cycles, in-
dicating that the cDNA present resulted from the conversion
of the RNA.
Statistical analysis
The data were analyzed by applying two-tailed indepen-
dent samples t tests. SPSS software was used to perform the
analysis. All tests were performed with a confidence level
of 95%.
Results
We have previously demonstrated that some combina-
tions of antibiotics are significantly effective against S. epi-
dermidis biofilm cells. Rifampicin alone was generally as or
more effective than when used in combination with other
antibiotics (Fig. 1). However, this kind of combinatorial
therapy aims to prevent the emergence of resistance usually
associated with monotherapy. Two of the most efficient
combinations that induced a greater reduction of bacterial
biofilm population and demonstrated a broader spectrum
range, being active against all strains tested, were rifampicin
plus clindamycin or gentamicin. Both these combinations
Table 2. List of the Primers Used
for the Real Time–Polymerase Chain
Reaction Experiments







FIG. 1. Effect of rifampicin (Rif), clindamycin (Clind), and
gentamicin (Gent) alone and in combination (RifþClind;
RifþGent) on 48-hour-old biofilm cells of five Staphylococcus
epidermidis clinical isolates, after overnight exposure. D Log
reduction¼differences between positive control (untreated
control: 6 log10 colony forming units/peg) and treated
samples in log10 colony forming units/peg. Error bars rep-
resent standard deviation. *Combinations statistically dif-
ferent from rifampicin alone ( p< 0.05).
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were able to reduce bacterial cell number by approximately 3
log (Fig. 1) for all strains tested.
To determine the effect of rifampicin, clindamycin and
gentamicin, and rifampicin combined with clindamycin or
gentamicin on gene expression of S. epidermidis icaA and rsbU
genes, real-time PCR analysis was performed. The results ob-
tained for the different strains tested are represented in Fig. 2.
Relative to the unexposed control, icaA and rsbU were
overexpressed in all strains when exposed to rifampicin at
break-point concentration ( p< 0.05), except for strain 132034
(Fig. 2B). The same was observed for gentamicin, which
caused the overexpression of both genes in four strains
( p< 0.05), with the exception of 1457 S. epidermidis. Generally,
no overexpression of icaA and rsbU genes was observed in
biofilm cells exposed to clindamycin. Relatively to combina-
tions of antibiotics, the response of S. epidermidis was strain
dependent. Three strains demonstrated overexpression of
both genes after exposure to rifampicinþ clindamycin and
rifampicinþ gentamicin when compared with untreated bio-
films ( p< 0.05). On the contrary, these two combinations in-
duced subexpression of icaA and rsbU on 1457 S. epidermidis.
On the other hand, in strain 150271, both combinations pro-
voked subexpression of icaA and the expression of rsbU was
unaffected comparatively to the positive control ( p< 0.05).
Comparing the effect of antibiotics alone and in combi-
nation, it was observed that the combinations always
FIG. 2. Expression of icaA and rsbU in S. epidermidis strains (A) 117977, (B) 132034, (C) 150271, (D) 1457, and (E) 9142, in
response to rifampicin (Rif), clindamycin (Clind), gentamicin (Gent), rifampicin combined with clindamycin (RifþClind),
and rifampicin with gentamicin (RifþGent). The relative expression of icaA and rsbU in biofilms exposed to antibiotics was
plotted against unexposed control biofilms (Cþ), using 16S as the reference gene. The 2DDCT was calculated from the average
cycle threshold (CT) values of two reactions. Error bars represent standard deviation.
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induced expression of icaA and rsbU genes in a lesser extent
than antibiotics individually. As clindamycin and gentamicin
are not active antimicrobial agents against S. epidermidis
biofilms (Fig. 1), and rifampicin was the only antibiotic
presenting similar effect to the most active combinations
tested (ca. 3 log reduction), it seems important to compare
the genetic expression of both genes after biofilm exposure to
these antimicrobial treatments. Therefore, although both
combinations of antibiotics induce an increase of icaA and
rsbU expression in response to an environmental stress, this
increase is not as marked as in cells exposed to rifampicin
alone. In fact, comparing the icaA and rsbU gene expression
after treatment with rifampicin and rifampicin combined
with clindamycin or gentamicin, we can conclude that, with
the exception of 132034, there is always a general decrease of
the expression of these two genes after biofilm exposure to
both combinations ( p< 0.05) (Fig. 2).
Discussion
Our results showed that normally the expression of icaA is
accompanied by the expression of rsbU. Pintens et al. dem-
onstrated that the increase in icaA expression clearly pre-
ceded the increase in rsbU expression in vitro as well as
in vivo.27 This is consistent with factors other than sigB in-
ducing icaADBC operon expression.3,18,19
RsbU is a positive regulator of the alternative sigma factor
sB, which is known to control PNAG/PIA synthesis at the
transcription level. Moreover, the global stress response reg-
ulator sB and rsbU control biofilm development in S. epi-
dermidis.12 The results clearly indicated that the expression of
icaA and rsbU is generally inferior in the presence of break-
point concentrations of rifampicin combined with clindamycin
or gentamicin in comparison to rifampicin alone. Although all
treatments studied induced the expression of the two genes
assayed, after overnight contact, rifampicin is a stronger in-
ducer of icaA and rsbU genes expression, possibly inducing in
S. epidermidis persister cells a high ability for biofilm forma-
tion. In fact, biofilm formation has been reported to be in-
duced by conditions that are potentially toxic for bacterial
cells, such as high levels of osmolarity, detergents, urea,
ethanol, oxidative stress, and the presence of sub-MICs
of some antibiotics such as tetracycline and quinupristin–
dalfopristin.4,13,28 In the present study, it was verified that a
toxic condition, caused by rifampicin exposure, promoted an
increased expression of icaA gene by surviving cells. In
S. epidermidis, the induction of PNAG/PIA production and
biofilm formation can improve the ability of biofilm immune
evasion. PNAG/PIA is crucial for connection of cells in a
biofilm, avoiding the detachment of biofilm cells, mechanism
that can make the cells more susceptible to antimicrobial
agents. Further, this exopolymer has also a protective func-
tion. Consequently, the induction of PNAG/PIA formation
can be a possible defense and resistance mechanism of cells.
Therefore, in addition to the already known advantages of
antibiotic combinatorial therapy, for example, as a strategy
to reduce resistance development, our results show that the
use of rifampicin combined with gentamicin and clin-
damycin may be a better therapy strategy and more effective
than rifampicin alone (the most efficient antibiotic against
S. epidermidis used in clinical practice). The combination
therapy, in addition to allowing for an almost equally ef-
fective killing of bacterial cells, results in lower expression of
icaA and rbsU, and consequently less PIA production, than if
rifampicin was used alone, thereby ensuring a more efficient
control of S. epidermidis biofilm-associated infections.
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